Abstract
Apoptosis is associated with cascades of biochemical changes, including caspase activation, cleavage of poly-ADP-ribose polymerase (PARP), and fragmentation of genomic DNA. Knowledge of the kinetics of these changes in drug-induced apoptosis is important for designing pharmacodynamic studies. We have shown that the slow manifestation of apoptosis contributes to the delayed pharmacological effects of paclitaxel (Cancer Res. 58:2141–2148, 1998). The present study examined the timing of the biochemical changes in paclitaxel-induced apoptosis in human prostate PC3 cancer cells. After treatment with 20 nM paclitaxel, the fraction of cells that detached from the culture flask increased with time to reach 68% at the end of the 96-hour experiment. In contrast, the control samples showed <1% detachment. The attached and detached paclitaxel-treated cells showed different biochemical properties. The detached cells exhibited the full spectrum of apoptotic changes, whereas the attached cells only showed activation of caspase-3-like proteases but not PARP cleavage, DNA fragmentation, nor release of DNA fragments to the cytoplasm. Activation of caspases in the attached cells was several-fold lower and occurred at a later time (ie, 24 vs 12 hours) compared to the detached cells. In the detached cells, caspase activation was first detected at 12 hours and peaked at 36 hours, whereas PARP cleavage was first detected at 24 hours and was completed prior to 72 hours. In contrast, the extent of internucleosomal DNA fragmentation and the release of DNA-histone complex to the cytoplasm (both were first detected at 24 hours) were cumulative over time up to the last time point of 96 hours. In summary, in paclitaxel-induced apoptosis, caspase activation was followed with a 12-hour lag time by PARP cleavage, internucleosomal DNA fragmentation, and release of DNA-histone complex to the cytoplasm. There was no detectable lag time between PARP cleavage and DNA fragmentation. The observation that only the detached cells but not the attached cells showed the full spectrum of apoptotic changes suggests that detachment is either a part of the initiation execution phases of apoptosis and or is required for their completion.
Similar content being viewed by others
References
Arbuck SG, Blaylock BA. Taxol: Clinical results and current issues in development. In: Suffness M. ed. Taxol: Science and Applications. Boca Raton, FL CRC Press, 1995:379–415.
Sciff PB, Horwitz SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 1980;77:1561–1565.
Bhalla K, Ilerado AM, Tourkina E, Tang C, Mahoney ME, Huang Y. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia. 1993;7:563–568.
Kerr JFR, Wyllie AH, Curie AR. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer. 1980;26:239–257.
Patel T, Gores GJ, Kaufimann SH. The role of proteases during apoptosis. FASEB J. 1996;10:587–597.
Arends MJ, Morris RG, Wyllie AH. Apoptosis: The role of endonucleases. Am J Pathol. 1990;136:593–608.
Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (London) 1980;284:555–556.
Neamati N, Fernandez A, Wright S, Kiefer J, McConkey DJ. Degradation of lamin B1 precedes oligonucleosomal DNA fragmentation in apoptotic thymocytes and isolated thymocyte neclei. J Immunol. 1995;154:3788–3795.
Lazebnik YA, Takahashi A, Moir RD, Goldman RD, Poirier GG. Kaufimann SH, Earnshaw WC. Studies of the lamin protease reveal multiple parallel biochemical pathways during apoptotic execution. Proc Natl Acad Sci USA 1995;92:9042–9046.
Voelkel-Johnson C, Entingh AJ, Wold WSM, Gooding LR, Laster SM. Activation of intracellular proteases is an early event in TNF-induced apoptosis. J Immunol 1995;153:4247–4255.
Wen LP, Fahmi JA, Troie S, Guan JL, Orth K, Rosen GD. Cleavage of focal adhesion kinase by caspases during apoptosis. J Biol Chem. 1997;272:26056–26061.
Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res. 1993;53:3976–3985.
Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirchner MW, Koths K, Kwiatkowski DJ, Williams LT. Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis. Science. 1997;278:294–298.
Rudel T, Bokoch GM. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science. 1997;276:1571–1574.
Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase 3 to trigger DNA fragmentation during apoptosis. Cell. 1997;89:175–184.
Collins JA, Schandl CA, Young KK, Vesely J, Willingham MC. Major DNA fragmentation is a late event in apoptosis. J Histol Cytometry. 1997;45:923–934.
Droin N, Dubrez L, Eymin B, Renvoize C, Breard J, Dimanche-Boitrel MT, Solary E. Upregulation of CASP genes in human tumor cells undergoing etoposide-induced apoptosis. Oncogene. 1998;16:2885–2894.
Benjamin CW, Hiebsch RR, Jones DA. Caspase activations in MF7 cells responding to etoposide treatment. Mol Phamacol. 1998;53:446–450.
Marcelli M, Cunninghain GR, Haidacher SJ, Padayatty SJ, Sturgis L, Kagan C, Denner L. Caspase 7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP. Cancer Res. 1998;58:76–83.
Ibrado AM, Huang Y, Fang G, Bhalla K. Bcl-xL over expression inhibits taxol-induced Yama protease activity and apoptosis. Cell Growth Differ. 1996;7:1087–1094.
Au JL-S, Li D, Gan Y, Gao X, Johnson AL, Johnson J, Millenbaugh NJ, Jang SH, Kuh H-J, Chen C-T, Wientjes MG. Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention. Cancer Res. 1998;58:2141–2148.
Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature (London) 1994;371:346–347.
Cohen GM. Caspases: The executioners of apoptosis. Biochem J. 1997;326:1–16.
Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493–501.
Moos PJ, Fitzpatrick FA. Taxanes propagate apoptosis via two cell populations with distinctive cytological and molecular traits. Cell Growth Differ. 1998;9:687–697.
Frisch SM, Francis H. Disruption of epithelial cell-matrix interaction induces apoptosis. J Cell Biol. 1994;124:619–626.
Frisch SM, Vuori K., Kelaita D, Sicks S. A role for Jun-N-terminal kinase in anoikis: suppression by Bcl-2 and crm A. J Cell Biol. 1996;135:1377–1382.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published: August 6, 1999.
Rights and permissions
About this article
Cite this article
Au, J.L.S., Wientjes, M.G., Kumar, R.R. et al. Kinetics of hallmark biochemical changes in paclitaxel-induced apoptosis. AAPS PharmSci 1, 8 (1999). https://doi.org/10.1208/ps010308
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/ps010308